|
|
|
| |
Investment Portfolio
|
|
| |
|
| |
AmpliMed® Corporation, a clinical-stage cancer pharmaceutical company founded by world-renowled oncologists, has a lead compound, AmpliMexon®, in Phase 1-2 clinical trials in monotherapy lymphoma (funded by NIH). The Company is focused on the development of small-molecule oncology drugs with novel mechanisms of action.
|
 |
| |
|
|
|
Ascent Healthcare Solutions is the leading independent reprocessor of medical devices for top hospitals and healthcare providers throughout North America. Since inception, Ascent customers have safely reprocessed in excess of 50 million medical devices, eliminating in excess of 10,000 tons from local landfills, and saving over $500 million from their costs by reprocessing and recycling medical products they would otherwise have needlessly thrown away. Working within strict safety and inspection protocols, Ascent is constantly pioneering ways to safely improve patient care by helping healthcare providers maximize limited resources. Ascent was sold to Stryker Corp. (NYSE:SYK) in December 2009.
|
|
| |
|
| |
AzERx, acquired by Capstone Therapeutics (OTC:CAPS.PK) in February 2006, is a biotechnology company committed to developing a pipeline of novel peptides. The Company is focused on the development and commercialization of two product platforms: Chrysalin® (TP508) and AZX100. Chrysalin targets acute myocardial infarction. AZX100 is a novel pre-clinical 24-amino acid peptide, the first of a new class of compounds in the field of smooth muscle relaxation/anti-fibrosis. AZX100 is currently being evaluated for medically and commercially significant applications, such as the prevention of dermal scarring and the treatment of pulmonary fibrosis. Capstone has an exclusive worldwide license to AZX100.
|
 |
| |
|
| |
Sold in 2008 to Life Technologies/Invitrogen (NASDAQ:LIFE), CellzDirect provides high-quality in-vitro ADME cell products and contract laboratory and consulting services focused primarily on drug metabolism and transport. Our clients include leaders in the pharmaceutical, biotech, academic, chemical and consumer products fields as well as government agencies. With CellzDirect’s support, scientists conduct research that accelerates the discovery of safe and effective drugs.
|
 |
| |
|
|
|
Delinea Corporation, acquired
by ONENECK IT SOLUTIOINS, is a vertical service provider (VSP)
that assists enterprises within the utilities, energy trading,
and petroleum refining and marketing industries in transforming
their business models to digital performance.
|
 |
| |
|
|
|
HTG is a Tucson-based company that has developed a powerful, proprietary “universal assay” and related products that enable high throughput drug screening, to help identify genes and other targets, validate those targets and provide quantitative and qualitative measurement of toxicity and metabolic effects of chemical compounds. Its proprietary FFPE capabilities enable development of biomarker diagnostic tests for oncology and other critical care pathologies.
|
|
| |
|
| |
InnovASIC Semiconductor designs and sells complex, highly-integrated imbedded microcontroller solutions and peripheral integrated circuits into the industrial, medical, automotive, consumer, communications and military markets. The Company has developed a new, proprietary class of imbedded microcontrollers serving the industrial ethernet market and is rapidly gaining OEM design wins on a worldwide basis. The replacement IC group has established itself as the leading supplier of extended life replacement semiconductors, replacing products discontinued by the original vendor. InnovASIC is on an aggressive growth pathway from its headquarters in Albuquerque, NM.
|
 |
| |
|
|
|
Quasar International, Inc., acquired
by Illinois Tool Works (NYSE: ITW), serves the nondestructive
inspection market in automotive component manufacturing with
a new, proprietary technology called Resonant Inspection (RI).
|
 |
| |
|
|
|
Regenesis Biomedical is a Scottsdale-based company in the tissue regeneration business. Regenesis is engaged in the research and development, manufacture, sale and marketing of novel electro-magnetic generating medical device that gives physicians, nurses and physical therapists the ability to promote healing and skin wound closure in less time and at a lower cost than the existing standard of wound care treatments.
|
|
| |
|
|
|
SiVerion provides proprietary software technology that enhances yield in the manufacturing of today’s complete silicon designs. The Company’s technology solution designers to embed test functionality into a semiconductor device. LogicVision (NASDAQ:LGVN), a leader in the built-in self-test market, acquired SiVerion to provide a closed loop solution to its customers to improve total yield. In August 2009, Mentor Graphics (NASDAQ:MENT), a market leader in the Engineering Design Automation software market for the semiconductor industry, acquired LogicVision for stock consideration.
|
|
| |
|
| |
Vital Therapies, Inc. (VTI) is engaged in the development of the ELAD® (Extracorporeal Liver Assist Device) System, which augments the metabolic functions of a patient’s liver, thereby enabling a bridge to transplant or liver recovery. VTI acquired the assets and business of VitaGen/Hepatix. VTI has completed a China pivotal trial (focused on Hepatitis B and C patients) and is awaiting SFDA approval to market in China.
|
 |
|
|
|
|
